KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.
Clinical trial NCT05149326 · UNKNOWN
Trial details
- NCT number
- NCT05149326
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2024-04-30
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.